BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30132166)

  • 1. UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
    Garner EF; Stafman LL; Williams AP; Aye JM; Goolsby C; Atigadda VR; Moore BP; Nan L; Stewart JE; Hjelmeland AB; Friedman GK; Beierle EA
    J Neurooncol; 2018 Nov; 140(2):209-224. PubMed ID: 30132166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro.
    Williams AP; Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
    J Surg Res; 2018 Aug; 228():54-62. PubMed ID: 29907230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts.
    Garner EF; Williams AP; Stafman LL; Aye JM; Mroczek-Musulman E; Moore BP; Stewart JE; Friedman GK; Beierle EA
    Sci Rep; 2018 May; 8(1):6913. PubMed ID: 29720672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts.
    Marayati R; Bownes LV; Stafman LL; Williams AP; Quinn CH; Atigadda V; Aye JM; Stewart JE; Yoon KJ; Beierle EA
    Transl Oncol; 2021 Jan; 14(1):100893. PubMed ID: 33010553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies.
    Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
    Mol Cancer Ther; 2016 May; 15(5):911-21. PubMed ID: 26873726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis.
    Chou CF; Hsieh YH; Grubbs CJ; Atigadda VR; Mobley JA; Dummer R; Muccio DD; Eto I; Elmets CA; Garvey WT; Chang PL
    J Dermatol Sci; 2018 Jun; 90(3):343-356. PubMed ID: 29599065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
    Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
    Mol Cancer Ther; 2015 Jul; 14(7):1559-69. PubMed ID: 25944918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells.
    Kim MS; Lim DY; Kim JE; Chen H; Lubet RA; Dong Z; Bode AM
    Mol Carcinog; 2015 Dec; 54(12):1596-604. PubMed ID: 25328014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid.
    Jiang W; Deng W; Bailey SK; Nail CD; Frost AR; Brouillette WJ; Muccio DD; Grubbs CJ; Ruppert JM; Lobo-Ruppert SM
    Cancer Biol Ther; 2009 Feb; 8(3):289-98. PubMed ID: 19197145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts.
    Williams AP; Garner EF; Stafman LL; Aye JM; Quinn CH; Marayati R; Stewart JE; Atigadda VR; Mroczek-Musulman E; Moore BP; Beierle EA; Friedman GK
    Transl Oncol; 2019 Oct; 12(10):1364-1374. PubMed ID: 31362265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on gene expression in rat liver after administration of RXR agonists: UAB30, 4-methyl-UAB30, and Targretin (Bexarotene).
    Vedell PT; Lu Y; Grubbs CJ; Yin Y; Jiang H; Bland KI; Muccio DD; Cvetkovic D; You M; Lubet R
    Mol Pharmacol; 2013 Mar; 83(3):698-708. PubMed ID: 23292798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.
    Marayati R; Williams AP; Bownes LV; Quinn CH; Stewart JE; Mroczek-Musulman E; Atigadda VR; Beierle EA
    J Pediatr Surg; 2020 Jun; 55(6):1072-1080. PubMed ID: 32164984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human Epidermis.
    Wu L; Chaudhary SC; Atigadda VR; Belyaeva OV; Harville SR; Elmets CA; Muccio DD; Athar M; Kedishvili NY
    PLoS One; 2016; 11(4):e0153556. PubMed ID: 27078158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention.
    Kapetanovic IM; Horn TL; Johnson WD; Cwik MJ; Detrisac CJ; McCormick DL
    Int J Toxicol; 2010; 29(2):157-64. PubMed ID: 20335511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenografts.
    Marayati R; Bownes LV; Quinn CH; Wadhwani N; Williams AP; Markert HR; Atigadda V; Aye JM; Stewart JE; Yoon KJ; Beierle EA
    J Pediatr Surg; 2021 Jun; 56(6):1165-1173. PubMed ID: 33762121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts.
    Evans AE; Kisselbach KD; Yamashiro DJ; Ikegaki N; Camoratto AM; Dionne CA; Brodeur GM
    Clin Cancer Res; 1999 Nov; 5(11):3594-602. PubMed ID: 10589776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts.
    Shu Q; Antalffy B; Su JM; Adesina A; Ou CN; Pietsch T; Blaney SM; Lau CC; Li XN
    Clin Cancer Res; 2006 Aug; 12(15):4687-94. PubMed ID: 16899619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans-retinoic acid induces cell growth arrest in a human medulloblastoma cell line.
    Chang Q; Chen Z; You J; McNutt MA; Zhang T; Han Z; Zhang X; Gong E; Gu J
    J Neurooncol; 2007 Sep; 84(3):263-7. PubMed ID: 17453147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
    Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P
    Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma.
    Spiller SE; Ravanpay AC; Hahn AW; Olson JM
    J Neurooncol; 2006 Sep; 79(3):259-70. PubMed ID: 16645722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.